AI-assisted, human-published
10/05/2026 /Funding Events
Oversubscribed Pre-Seed Round Fuels SereNeuro’s Non-Opioid Pain Programs
SereNeuro secures oversubscribed pre-seed funding to push SN101 toward IND-enabling work and advance SN102, signaling strong investor confidence in non-opioid analgesia.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com